News Release

Depression common during perimenopause but not regularly assessed by providers

New study documents lack of screening for depression and need to better educate healthcare providers on women's mental health issues during the menopause transition

Peer-Reviewed Publication

The Menopause Society

CLEVELAND, Ohio (January 21, 2020)--Almost 40% of women experience symptoms of depression during perimenopause, yet it often goes undetected and untreated because many healthcare providers aren't screening for it and aren't prepared with treatment options. A new study analyzed screening practices by women's healthcare providers and their management of depression during perimenopause. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

The high number of women experiencing symptoms of depression has been linked to hormone changes, historical depressive episodes, life events, and a genetic predisposition to depression. As more data emerges to support the presence of risk factors for depression during perimenopause and as the patient population continues to age, healthcare providers need to become better educated in order to recognize and manage depression.

Rates of routine screening and healthcare-provider beliefs and knowledge about symptoms of depression in perimenopause remained unstudied until now. The aim of this new study was to better understand clinical practice patterns of obstetrician-gynecologists regarding their screening practices and management of depression.

The survey was sent to 500 practicing obstetrician-gynecologists who were fellows of the American College of Obstetricians and Gynecologists and members of the Collaborative Ambulatory Research Network. It found that more than a third of respondents (34.1%) did not regularly screen perimenopausal women for depression and that more than half (55%) believed they were not equipped to manage the problem.

Higher-quality education about depression was associated with higher rates of screening. These findings suggest that improved training for obstetrician-gynecologists in the diagnosis, treatment, and management of depression, both in residency and later, could improve rates of screening.

Study results appear in the article "Obstetrician-gynecologists' screening and management of depression during perimenopause."

"Given the prevalence of depressive symptoms in perimenopausal women, the recent publication of guidelines for the diagnosis and management of depression in this population, and the availability of safe and effective therapies, all healthcare providers should be screening their female patients for depression. Improving training for healthcare providers in the evaluation and treatment of depression is important to optimizing patient outcomes," says Dr. Stephanie Faubion, NAMS medical director.


For more information about menopause and healthy aging, visit

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.